Y-3 Intracalvariosseous Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Y-3 Intracalvariosseous Injection, covering 2025-01-28 to 2025-01-28. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction [NA]